Click Chemistry Applications in Pharmaceutical Development

Click chemistry, encompassing a suite of rapid, modular and chemoselective reactions, has revolutionised the synthesis and optimisation of pharmaceutically relevant molecules. Central to this field is the copper-catalysed azide–alkyne cycloaddition (CuAAC), which affords 1,4-disubstituted triazoles under mild conditions, and its ruthenium-catalysed counterpart (RuAAC) yielding complementary regiochemistry. These reactions enable efficient assembly of small-molecule libraries, the construction of drug–polymer conjugates and the installation of imaging or targeting moieties on biomolecules. Beyond cycloadditions, bioorthogonal ligations such as inverse-electron-demand tetrazine–trans-cyclooctene chemistry have expanded in vivo applications, facilitating prodrug activation, real-time biomarker labelling and controlled drug release. The high yields, broad functional-group tolerance and predictable kinetics of click reactions underpin diverse pharmaceutical endeavours, from hit-to-lead optimisation to site-selective bioconjugation for antibody–drug conjugates and radiopharmaceuticals. Emerging advances in heterogeneous catalysts, flow-chemistry integration and redox-responsive click pairs are driving improved scalability, reduced metal contamination and spatiotemporal control in medicinal chemistry workflows.

Research from Nature Portfolio

Recent studies have demonstrated the utility of copper nanoparticles as heterogeneous catalysts for click cycloadditions, combining superior catalyst recovery with mechanistic insight at the single-molecule level. Through real-time single-molecule spectroscopy, researchers have shown that azide–alkyne cycloaddition occurs directly at nanoparticle surfaces without significant metal-ion leaching, validating the robustness of heterogeneous catalysts in drug-development processes. This fundamental understanding informs the design of recyclable, high-surface-area catalysts that maintain activity in complex reaction media, offering a route to sustainable large-scale synthesis of triazole-based drug candidates and bioconjugates.

Click Chemistry Applications in Pharmaceutical Development publication trend

The graph below shows the total number of articles in click chemistry applications in pharmaceutical development across all publications each year (not limited to Nature Index journals).

Technical terms

Click chemistry: A class of high-yielding, modular reactions characterised by simple conditions, wide functional-group tolerance and rapid kinetics.

Copper-catalysed azide–alkyne cycloaddition (CuAAC): A click reaction forming 1,4-disubstituted 1,2,3-triazoles via Cu(I) catalysis under mild conditions.

Ruthenium-catalysed azide–alkyne cycloaddition (RuAAC): A complementary click reaction producing 1,5-disubstituted triazoles utilising Ru(II) catalysts.

Bioorthogonal reaction: A chemical transformation that proceeds selectively in living systems without perturbing native biochemical processes.

Heterogeneous catalyst: A solid catalyst operating in a different phase from the reactants, enabling facile separation and reuse.

Triazole: A five-membered heterocycle containing three nitrogen atoms, frequently employed as a stable linker or pharmacophore in drug molecules.

References

1. Glutathione Mediates Control of Dual Differential Bio‐orthogonal Labelling of Biomolecules. Angewandte Chemie International Edition (2023).
2. Copper nanoparticle heterogeneous catalytic ‘click’ cycloaddition confirmed by single-molecule spectroscopy. Nature Communications (2014).
3. Ruthenium-Catalyzed Azide Alkyne Cycloaddition Reaction: Scope, Mechanism, and Applications. Chemical Reviews (2016).
4. Triazoles and Their Derivatives: Chemistry, Synthesis, and Therapeutic Applications. Frontiers in Molecular Biosciences (2022).